Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Timothy Lu
person4 mentionslast seen Nov 10, 2026
Chief Executive Officer of Senti Biosciences Holdings, Inc.
Relationships 1
Relationship
Senti Biosciences Holdings, Inc.employsTimothy Lu
99% confidence4 supporting mentions
Either name opens that entity’s relationships.
Sources 4
- filingSEC EDGARNov 10, 2026Senti Biosciences Holdings, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 3.02: Unregistered Sales of Equity Securities; Item 9.01: Financial Statements and Exhibits
Timothy Lu, M.D., Ph.D. Title: Chief Executive Officer
- filingSEC EDGAROct 27, 2026Senti Biosciences Holdings, Inc. 8-K: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Item 8.01: Other Events
Timothy Lu, M.D., Ph.D. Title: Chief Executive Officer
- filingSEC EDGAROct 26, 2026Senti Biosciences Holdings, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 1.02: Termination of a Material Definitive Agreement; Item 2.01: Completion of Acquisition or Disposition of Assets; Item 3.02: Unregistered Sales of Equity Securities; Item 9.01: Financial Statements and Exhibits
Timothy Lu, M.D., Ph.D. Title: Chief Executive Officer
- filingSEC EDGAROct 13, 2026Senti Biosciences Holdings, Inc. 8-K: Item 8.01: Other Events
Timothy Lu, M.D., Ph.D. Title: Chief Executive Officer